Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Post-pericardiocentesis Constrictive Physiology in Cancer Patients With Pericardial Effusion

  • In-Jeong Cho (Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine)
  • Received : 2021.11.16
  • Accepted : 2021.11.19
  • Published : 2022.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology 2013;124:224-32. https://doi.org/10.1159/000348559
  2. Imazio M. Pericardiocentesis with extended drainage and colchicine: new indication for malignant pericardial effusions? J Am Coll Cardiol 2020;76:1562-3. https://doi.org/10.1016/j.jacc.2020.08.008
  3. Sagrista-Sauleda J, Angel J, Sanchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med 2004;350:469-75. https://doi.org/10.1056/NEJMoa035630
  4. Miranda WR, Newman DB, Oh JK. Effusive-constrictive pericarditis: Doppler findings. Curr Cardiol Rep 2019;21:144.
  5. Kim KH, Miranda WR, Sinak LJ, et al. Effusive-constrictive pericarditis after pericardiocentesis: incidence, associated findings, and natural history. JACC Cardiovasc Imaging 2018;11:534-41. https://doi.org/10.1016/j.jcmg.2017.06.017
  6. Cho IJ, Chang HJ, Chung H, et al. Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion. PLoS One 2015;10:e0145461.
  7. Kim SR, Kim EK, Cho J, et al. Effect of anti-inflammatory drugs on clinical outcomes in patients with malignant pericardial effusion. J Am Coll Cardiol 2020;76:1551-61. https://doi.org/10.1016/j.jacc.2020.08.003
  8. Park H, Yoon HJ, Lee N, et al. Characteristics and clinical outcomes of cancer patients who developed constrictive physiology after pericardiocentesis. Korean Circ J 2022;52:74-83. https://doi.org/10.4070/kcj.2021.0217